Lice Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Pediculosis Capitis, Pediculosis Corporis, Pediculosis Pubis), By Drugs (OTC Drugs, Prescription Drugs), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) By Region & Competition, 2021-2031F

January 2026 | 180 pages | ID: LE48D2175825EN
TechSci Research

Abstracts

The Global Lice Treatment Market will grow from USD 1.14 Billion in 2025 to USD 1.57 Billion by 2031 at a 5.48% CAGR. The Global Lice Treatment Market encompasses topical pediculicides, such as shampoos and lotions, alongside mechanical removal devices designed for the eradication of pediculosis infestations. The market’s trajectory is fundamentally supported by the persistent prevalence of head lice among school-aged children and the expanding accessibility of over-the-counter therapeutic options.

Key Market Drivers

The escalating prevalence of pediculosis capitis among school-aged children serves as a primary catalyst for the sustained growth of the lice treatment market. This condition spreads rapidly in educational and childcare settings through direct head-to-head contact, creating a cyclical demand for effective eradication solutions. As classrooms and extracurricular activities facilitate transmission, the sheer volume of infestations necessitates frequent therapeutic interventions by parents and guardians.

Key Market Challenges

The escalating biological resistance of head lice to pyrethroid-based formulations constitutes a formidable barrier to the growth of the Global Lice Treatment Market. This physiological adaptation, observed in strains widely known as 'super lice,' renders many standard over-the-counter pediculicides ineffective. When these established chemical treatments fail to eradicate infestations, consumer confidence in conventional product lines diminishes significantly.

Key Market Trends

The market is witnessing a decisive transition toward non-toxic and physical mode-of-action formulations as a response to the widespread resistance of lice to traditional pyrethroid-based treatments. Consumers and healthcare providers are increasingly favoring products containing ingredients like spinosad or dimethicone, which utilize mechanical or novel biological mechanisms to eradicate infestations rather than relying on neurotoxic chemicals. This shift is driving significant revenue growth for pharmaceutical companies holding rights to these advanced therapies.

Key Market Players

• Alliance Pharmaceuticals
• Omega Pharma
• Prestige Brands Holdings Inc.
• Johnson & Johnson
• Fleming Medical Ltd
• Oystershell Consumer Health, Inc
• Nisarg Pharma
• ParaPRO Pharmaceuticals
• ICB Pharma
• Marico

Report Scope:

In this report, the Global Lice Treatment Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Lice Treatment Market, By Type:
• Pediculosis Capitis
• Pediculosis Corporis
• Pediculosis Pubis
• Lice Treatment Market, By Drugs:
• OTC Drugs
• Prescription Drugs
• Lice Treatment Market, By Distribution Channel:
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Lice Treatment Market, By Region:
• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Lice Treatment Market.

Available Customizations:

Global Lice Treatment Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Contents

1. PRODUCT OVERVIEW

1.1. Market Definition
1.2. Scope of the Market
  1.2.1. Markets Covered
  1.2.2. Years Considered for Study
  1.2.3. Key Market Segmentations

2. RESEARCH METHODOLOGY

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. EXECUTIVE SUMMARY

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. VOICE OF CUSTOMER

5. GLOBAL LICE TREATMENT MARKET OUTLOOK

5.1. Market Size & Forecast
  5.1.1. By Value
5.2. Market Share & Forecast
  5.2.1. By Type (Pediculosis Capitis, Pediculosis Corporis, Pediculosis Pubis)
  5.2.2. By Drugs (OTC Drugs, Prescription Drugs)
  5.2.3. By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)
  5.2.4. By Region
  5.2.5. By Company (2025)
5.3. Market Map

6. NORTH AMERICA LICE TREATMENT MARKET OUTLOOK

6.1. Market Size & Forecast
  6.1.1. By Value
6.2. Market Share & Forecast
  6.2.1. By Type
  6.2.2. By Drugs
  6.2.3. By Distribution Channel
  6.2.4. By Country
6.3. North America: Country Analysis
  6.3.1. United States Lice Treatment Market Outlook
    6.3.1.1. Market Size & Forecast
      6.3.1.1.1. By Value
    6.3.1.2. Market Share & Forecast
      6.3.1.2.1. By Type
      6.3.1.2.2. By Drugs
      6.3.1.2.3. By Distribution Channel
  6.3.2. Canada Lice Treatment Market Outlook
    6.3.2.1. Market Size & Forecast
      6.3.2.1.1. By Value
    6.3.2.2. Market Share & Forecast
      6.3.2.2.1. By Type
      6.3.2.2.2. By Drugs
      6.3.2.2.3. By Distribution Channel
  6.3.3. Mexico Lice Treatment Market Outlook
    6.3.3.1. Market Size & Forecast
      6.3.3.1.1. By Value
    6.3.3.2. Market Share & Forecast
      6.3.3.2.1. By Type
      6.3.3.2.2. By Drugs
      6.3.3.2.3. By Distribution Channel

7. EUROPE LICE TREATMENT MARKET OUTLOOK

7.1. Market Size & Forecast
  7.1.1. By Value
7.2. Market Share & Forecast
  7.2.1. By Type
  7.2.2. By Drugs
  7.2.3. By Distribution Channel
  7.2.4. By Country
7.3. Europe: Country Analysis
  7.3.1. Germany Lice Treatment Market Outlook
    7.3.1.1. Market Size & Forecast
      7.3.1.1.1. By Value
    7.3.1.2. Market Share & Forecast
      7.3.1.2.1. By Type
      7.3.1.2.2. By Drugs
      7.3.1.2.3. By Distribution Channel
  7.3.2. France Lice Treatment Market Outlook
    7.3.2.1. Market Size & Forecast
      7.3.2.1.1. By Value
    7.3.2.2. Market Share & Forecast
      7.3.2.2.1. By Type
      7.3.2.2.2. By Drugs
      7.3.2.2.3. By Distribution Channel
  7.3.3. United Kingdom Lice Treatment Market Outlook
    7.3.3.1. Market Size & Forecast
      7.3.3.1.1. By Value
    7.3.3.2. Market Share & Forecast
      7.3.3.2.1. By Type
      7.3.3.2.2. By Drugs
      7.3.3.2.3. By Distribution Channel
  7.3.4. Italy Lice Treatment Market Outlook
    7.3.4.1. Market Size & Forecast
      7.3.4.1.1. By Value
    7.3.4.2. Market Share & Forecast
      7.3.4.2.1. By Type
      7.3.4.2.2. By Drugs
      7.3.4.2.3. By Distribution Channel
  7.3.5. Spain Lice Treatment Market Outlook
    7.3.5.1. Market Size & Forecast
      7.3.5.1.1. By Value
    7.3.5.2. Market Share & Forecast
      7.3.5.2.1. By Type
      7.3.5.2.2. By Drugs
      7.3.5.2.3. By Distribution Channel

8. ASIA PACIFIC LICE TREATMENT MARKET OUTLOOK

8.1. Market Size & Forecast
  8.1.1. By Value
8.2. Market Share & Forecast
  8.2.1. By Type
  8.2.2. By Drugs
  8.2.3. By Distribution Channel
  8.2.4. By Country
8.3. Asia Pacific: Country Analysis
  8.3.1. China Lice Treatment Market Outlook
    8.3.1.1. Market Size & Forecast
      8.3.1.1.1. By Value
    8.3.1.2. Market Share & Forecast
      8.3.1.2.1. By Type
      8.3.1.2.2. By Drugs
      8.3.1.2.3. By Distribution Channel
  8.3.2. India Lice Treatment Market Outlook
    8.3.2.1. Market Size & Forecast
      8.3.2.1.1. By Value
    8.3.2.2. Market Share & Forecast
      8.3.2.2.1. By Type
      8.3.2.2.2. By Drugs
      8.3.2.2.3. By Distribution Channel
  8.3.3. Japan Lice Treatment Market Outlook
    8.3.3.1. Market Size & Forecast
      8.3.3.1.1. By Value
    8.3.3.2. Market Share & Forecast
      8.3.3.2.1. By Type
      8.3.3.2.2. By Drugs
      8.3.3.2.3. By Distribution Channel
  8.3.4. South Korea Lice Treatment Market Outlook
    8.3.4.1. Market Size & Forecast
      8.3.4.1.1. By Value
    8.3.4.2. Market Share & Forecast
      8.3.4.2.1. By Type
      8.3.4.2.2. By Drugs
      8.3.4.2.3. By Distribution Channel
  8.3.5. Australia Lice Treatment Market Outlook
    8.3.5.1. Market Size & Forecast
      8.3.5.1.1. By Value
    8.3.5.2. Market Share & Forecast
      8.3.5.2.1. By Type
      8.3.5.2.2. By Drugs
      8.3.5.2.3. By Distribution Channel

9. MIDDLE EAST & AFRICA LICE TREATMENT MARKET OUTLOOK

9.1. Market Size & Forecast
  9.1.1. By Value
9.2. Market Share & Forecast
  9.2.1. By Type
  9.2.2. By Drugs
  9.2.3. By Distribution Channel
  9.2.4. By Country
9.3. Middle East & Africa: Country Analysis
  9.3.1. Saudi Arabia Lice Treatment Market Outlook
    9.3.1.1. Market Size & Forecast
      9.3.1.1.1. By Value
    9.3.1.2. Market Share & Forecast
      9.3.1.2.1. By Type
      9.3.1.2.2. By Drugs
      9.3.1.2.3. By Distribution Channel
  9.3.2. UAE Lice Treatment Market Outlook
    9.3.2.1. Market Size & Forecast
      9.3.2.1.1. By Value
    9.3.2.2. Market Share & Forecast
      9.3.2.2.1. By Type
      9.3.2.2.2. By Drugs
      9.3.2.2.3. By Distribution Channel
  9.3.3. South Africa Lice Treatment Market Outlook
    9.3.3.1. Market Size & Forecast
      9.3.3.1.1. By Value
    9.3.3.2. Market Share & Forecast
      9.3.3.2.1. By Type
      9.3.3.2.2. By Drugs
      9.3.3.2.3. By Distribution Channel

10. SOUTH AMERICA LICE TREATMENT MARKET OUTLOOK

10.1. Market Size & Forecast
  10.1.1. By Value
10.2. Market Share & Forecast
  10.2.1. By Type
  10.2.2. By Drugs
  10.2.3. By Distribution Channel
  10.2.4. By Country
10.3. South America: Country Analysis
  10.3.1. Brazil Lice Treatment Market Outlook
    10.3.1.1. Market Size & Forecast
      10.3.1.1.1. By Value
    10.3.1.2. Market Share & Forecast
      10.3.1.2.1. By Type
      10.3.1.2.2. By Drugs
      10.3.1.2.3. By Distribution Channel
  10.3.2. Colombia Lice Treatment Market Outlook
    10.3.2.1. Market Size & Forecast
      10.3.2.1.1. By Value
    10.3.2.2. Market Share & Forecast
      10.3.2.2.1. By Type
      10.3.2.2.2. By Drugs
      10.3.2.2.3. By Distribution Channel
  10.3.3. Argentina Lice Treatment Market Outlook
    10.3.3.1. Market Size & Forecast
      10.3.3.1.1. By Value
    10.3.3.2. Market Share & Forecast
      10.3.3.2.1. By Type
      10.3.3.2.2. By Drugs
      10.3.3.2.3. By Distribution Channel

11. MARKET DYNAMICS

11.1. Drivers
11.2. Challenges

12. MARKET TRENDS & DEVELOPMENTS

12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments

13. GLOBAL LICE TREATMENT MARKET: SWOT ANALYSIS

14. PORTER'S FIVE FORCES ANALYSIS

14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products

15. COMPETITIVE LANDSCAPE

15.1. Alliance Pharmaceuticals
  15.1.1. Business Overview
  15.1.2. Products & Services
  15.1.3. Recent Developments
  15.1.4. Key Personnel
  15.1.5. SWOT Analysis
15.2. Omega Pharma
15.3. Prestige Brands Holdings Inc.
15.4. Johnson & Johnson
15.5. Fleming Medical Ltd
15.6. Oystershell Consumer Health, Inc
15.7. Nisarg Pharma
15.8. ParaPRO Pharmaceuticals
15.9. ICB Pharma
15.10. Marico

16. STRATEGIC RECOMMENDATIONS

17. ABOUT US & DISCLAIMER